Deleterious variations in genes responsible for the control of BK release, as SERPING1, or its metabolization, as CPN, CPM, angiotensin-converting enzyme (ACE), and neprilysin (MME), are able to increase the amount of BK released or its half-life, leading to or intensifying angioedema episodes. The gene discussed is ACE; the disease is angioedema.